Abstract
Cytosine arabinoside and daunorubicin used in an intensive intermittent regimen have been shown to be an effective combination for the induction of complete remissions in 14 out of 23 adult patients with acute myelogenous leukaemia. This gives an overall complete remission rate of 60%. A further patient had a good partial remission. The addition of L-asparaginase to the regimen has not increased the incidence of remission and there were more side effects in the L-asparaginasetreated group. Of the 10 patients treated with L-asparaginase in addition to cytosine arabinoside and daunorubicin, five achieved a complete remission. Of the 13 patients treated with cytosine arabinoside and daunorubicin without L-asparaginase, nine achieved a complete remission and one a good partial remission.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beard M. E., Crowther D., Galton D. A., Guyer R. J., Fairley G. H., Kay H. E., Knapton P. J., Malpas J. S., Scott R. B. L-asparaginase in treatment of acute leukaemia and lymphosarcoma. Br Med J. 1970 Jan 24;1(5690):191–195. doi: 10.1136/bmj.1.5690.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boiron M., Weil M., Jacquillat C., Tanzer J., Levy D., Sultan C., Bernard J. Daunorubicin in the treatment of acute myelocytic leukaemia. Lancet. 1969 Feb 15;1(7590):330–333. doi: 10.1016/s0140-6736(69)91296-3. [DOI] [PubMed] [Google Scholar]
- Di Marco A. Mechanism of action of daunomycin. Acta Genet Med Gemellol (Roma) 1968 Jan;17(1):102–121. doi: 10.1017/s1120962300026330. [DOI] [PubMed] [Google Scholar]
- Ellison R. R., Holland J. F., Weil M., Jacquillat C., Boiron M., Bernard J., Sawitsky A., Rosner F., Gussoff B., Silver R. T. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood. 1968 Oct;32(4):507–523. [PubMed] [Google Scholar]
- Gee T. S., Yu K. P., Clarkson B. D. Treatment of adult acute leukemia with arabinosylcytosine and thioguanine. Cancer. 1969 May;23(5):1019–1032. doi: 10.1002/1097-0142(196905)23:5<1019::aid-cncr2820230506>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
- Hill J. M., Loeb E., MacLellan A., Khan A., Roberts J., Shields W. F., Hill N. O. Response to highly purified L-asparaginase during therapy of acute leukemia. Cancer Res. 1969 Aug;29(8):1574–1580. [PubMed] [Google Scholar]